ask="0.60"
ask_size="900"
average_daily_volume="30468"
bid="N/A"
bid_size="N/A"
book_value="0.28"
change="-0.01"
change_from_200_day_moving_average="-0.26"
change_from_50_day_moving_average="-0.05"
change_from_52_week_high="-0.97"
change_From_52_week_low="0.09"
change_in_percent="-1.64%"
close="0.60"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.26"
ebitda="-2.11M"
eps_estimate_current_year="-0.02"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-0.02"
ex_dividend_date="N/A"
float_shares="9122000"
high="0.62"
high_52_weeks="1.57"
last_trade_date="2/8/2017"
last_trade_price="0.60"
last_trade_size="500"
last_trade_time="4:00pm"
low="0.58"
low_52_weeks="0.51"
market_capitalization="8.04M"
moving_average_200_day="0.86"
moving_average_50_day="0.65"
name="XTL Biopharmaceuticals Ltd."
notes="N/A"
one_year_target_price="6.00"
open="0.59"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-30.29%"
percent_change_from_50_day_moving_average="-7.56%"
percent_change_from_52_week_high="-61.78%"
percent_change_from_52_week_low="+17.65%"
previous_close="0.61"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.18"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="13400000"
short_ratio="0.45"
stock_exchange="NCM"
symbol="XTLB"
volume="16035"
weeks_range_52="0.51 - 1.57"
